Stockscreener 앱 받기
21.73
4.42%
0.92
시간 외 거래:
21.98
0.25
+1.15%
전일 마감가:
$20.81
열려 있는:
$20.79
하루 거래량:
308.75K
Relative Volume:
0.73
시가총액:
$806.09M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.09%
1개월 성능:
+10.19%
6개월 성능:
+14.79%
1년 성능:
-3.64%
1일 변동 폭
$20.64
$21.75
1주일 범위
$20.39
$22.96
52주 변동 폭
$10.01
$26.04
Ceribell Inc Stock (CBLL) Company Profile
명칭
Ceribell Inc
전화
(800) 436-0826
주소
360 N. PASTORIA AVENUE, SUNNYVALE
CBLL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
21.73 | 771.96M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
127.78 | 219.88B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
97.79 | 141.54B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
366.39 | 133.39B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.31 | 124.82B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
85.85 | 48.84B | 5.88B | 1.34B | 799.60M | 2.3489 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-21 | 개시 | Raymond James | Strong Buy |
| 2025-06-24 | 개시 | BTIG Research | Buy |
| 2025-04-04 | 개시 | Ladenburg Thalmann | Buy |
| 2024-11-05 | 개시 | BofA Securities | Buy |
| 2024-11-05 | 개시 | Canaccord Genuity | Buy |
| 2024-11-05 | 개시 | JP Morgan | Overweight |
| 2024-11-05 | 개시 | TD Cowen | Buy |
| 2024-11-05 | 개시 | William Blair | Outperform |
모두보기
Ceribell Inc 주식(CBLL)의 최신 뉴스
Will CeriBell Inc. stock benefit from infrastructure spending2026 world cup usa national team group stage star players transition play winner prediction breakdown - Улправда
Ceribell Gets FDA Breakthrough Device Status - Medical Device and Diagnostic industry
Ceribell’s AI Stroke Detection Tool Gains FDA Breakthrough Status - Zenopa
CBLL Wins FDA Breakthrough Status for AI-Based LVO Stroke Detection - TradingView — Track All Markets
FDA grants breakthrough designation for Ceribell’s stroke detection monitor By Investing.com - Investing.com Nigeria
Ceribell receives FDA breakthrough device designation for LVO SD monitor - TipRanks
CeriBell (NASDAQ:CBLL) Hits New 12-Month HighHere's Why - MarketBeat
Ceribell Wins FDA Breakthrough Status for LVO Stroke Tool - TipRanks
Ceribell, Inc. Receives FDA Breakthrough Device Designation for LVO Stroke Solution - TradingView — Track All Markets
Ceribell shares advance after FDA grants breakthrough device status - MSN
Ceribell receives FDA breakthrough device designation for LVO stroke detection - marketscreener.com
Ceribell’s LVO Stroke Detection Monitor Wins FDA Breakthrough Nod - Medical Product Outsourcing
CeriBell stock climbs after FDA Breakthrough Device Designation By Investing.com - Investing.com Australia
FDA grants breakthrough designation for Ceribell’s stroke detection monitor - Investing.com
FDA highlights new brain monitor that may spot deadly hospital strokes sooner - Stock Titan
Ceribell director Lucian Iancovici resigns from board and committees By Investing.com - Investing.com South Africa
Ceribell director resigns to pursue other professional ventures - TipRanks
Ceribell director Lucian Iancovici resigns from board and committees - Investing.com
Ceribell, Inc. Announces Board Resignation - TradingView — Track All Markets
CeriBell, Inc. Announces Resignation of Lucian Iancovici as Chair of the Nominating and Corporate Governance Committee and as Member of the Compensation Committee, Effective as of December 31, 2025 - marketscreener.com
CeriBell stock climbs after FDA Breakthrough Device Designation - Investing.com
Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewswire
CeriBell (NASDAQ:CBLL) CFO Sells $756,000.00 in Stock - MarketBeat
Ceribell’s CFO Blumberg sells $756k in shares - Investing.com India
Ceribell’s CFO Blumberg sells $756k in shares By Investing.com - Investing.com Australia
CeriBell (NASDAQ:CBLL) Trading 3.4% HigherHere's What Happened - MarketBeat
CeriBell, Inc. (CBLL) Eps Diluted (Quarterly) - Zacks Investment Research
CeriBell raises 2025 revenue guidance to $89M while targeting deeper hospital penetration and expanding pediatric market - MSN
Ceribell (CBLL) price target increased by 13.29% to 28.56 - MSN
Squarepoint Ops LLC Takes Position in CeriBell, Inc. $CBLL - MarketBeat
CeriBell (CBLL) Price Target Increased by 13.29% to 28.56 - Nasdaq
Aug Catalysts: Will CeriBell Inc. stock rally after Fed decisions2025 Momentum Check & Safe Entry Point Identification - moha.gov.vn
Will CeriBell Inc. stock rally after Fed decisionsGlobal Markets & AI Enhanced Trade Execution Alerts - DonanımHaber
Is CeriBell Inc. stock a buy on dipsQuarterly Market Summary & Growth Focused Entry Point Reports - Улправда
Why CeriBell Inc. stock could outperform in 2025Day Trade & Daily Entry Point Trade Alerts - Улправда
Market Fear: Why CeriBell Inc. stock could outperform in 2025Weekly Profit Report & Reliable Price Breakout Signals - Улправда
Ceribell management to meet virtually with BTIG - MSN
Is CeriBell Inc. stock attractive for income investorsMarket Risk Report & Low Risk High Reward Trade Ideas - Улправда
Ceribell price target raised to $30 from $29 at Canaccord - TipRanks
CeriBell (NASDAQ:CBLL) Director Sells $537,250.00 in Stock - MarketBeat
Officer/Dir Parvizi Sells 25,000 ($537.3K) Of CeriBell Inc [CBLL] - TradingView — Track All Markets
Canaccord Genuity Maintains CeriBell (CBLL) Buy Recommendation - Nasdaq
CeriBell (CBLL): Canaccord Genuity Raises Price Target to $30 | - GuruFocus
Canaccord Genuity Group Increases CeriBell (NASDAQ:CBLL) Price Target to $30.00 - MarketBeat
CeriBell, Inc. (NASDAQ:CBLL) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Ceribell, Inc. (CBLL) Gets a Buy from BTIG - The Globe and Mail
BTIG Reiterates CeriBell (CBLL) Buy Recommendation - Nasdaq
Ceribell stock price target reiterated at $30 by BTIG, citing growth - Investing.com South Africa
BTIG Reiterates Buy Rating for CeriBell (CBLL) With Target Price of $30 | CBLL Stock News - GuruFocus
Ceribell, Inc. Extends Sunnyvale Office Leases - The Globe and Mail
Ceribell extends leases for Sunnyvale offices through January 2028 By Investing.com - Investing.com Nigeria
Ceribell Inc (CBLL) 재무 분석
Ceribell Inc (CBLL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
3.82%
자본화:
|
볼륨(24시간):